 This programme aims to make the process of clinical trials quicker and easier within the UK.TAP links 13 treatment centres coordinated by a central hub in Birmingham to set up more clinical trials in blood cancer.Because of this geographical spread, it means 20 million people in the UK could have access to the very latest promising blood cancer treatments, if they needed it.